Swing Trading mostly tech stocks since 2007, with a critical eye to spot bs claims, and considering opportunities to short using short-term put options, with small account size < 25k. Goals: grow account size while minimizing risk using tech analysis to set entrance and exit levels, using candlestick and slow stochastics to forecast short term trading activity less than 5 days timeframe.
Investing for 25 years has given me many great and some painful insights into the stock markets. I have honed my investment philosophy in that time,and seek companies with the following:
1. High barriers to entry
2. Operating Margin > 10%
3. strong positive cash flow over multiple years
4. Paying a regular dividend, usually between 2 and 4.5%
Team StockMatusow.com research and writers are:
Scott Matusow; Team Leader, owner and founder of StockMatusow.com and Dan Cohen, partner, and independent investor/scientist/inventor/trader and lead contributor at stockmatusow.com.
Scott is an independent investor/writer/trader and team leader of StockMatusow.com.
He has have about 17 years of stock market experience which include trading, investing, and managing his family’s trust as well as his personal account.
Scott has had the most success in trading/investing in smaller cap growth companies. Because Scott is not 'officially trained' in the markets, he see things outside the box, using his experience to provide clarity and alpha. Scott uses his ability to read situations, emotion, charts, times and sales, historical data, and macroeconomic and other market forces to predict stock price movements, in both short and longer terms situations.. Using these acquired allowed for him to completely divest his own and family's money near the top of the market before the 2008 financial crisis.
Dan Cohen is a partner at stockmatusow and entrepreneur in the fields of nanotechnology, medical diagnostics, and energy storage. Additionally, Dan is a Scientist and inventor. He has 7 years of experience investing and trading biotechnology focused equities with a specialty in identifying under-appreciated value in small caps. Dan utilizes his experience reading and reviewing scientific literature to evaluate prospects for success. His work with diagnostics development give him a strong background in immunology which is leveraged in evaluating immunoncology focused approaches. As well Dan has 5 years trading futures, specializing in E-minis and Treasury products. He utilizes a combination of technical analysis, deep scientific research, and macro views to generate alpha for the team.
Places you can follow Scott are:
Places to follow Dan are:
I am an ex-con and a former heroin addict/carrier criminal. I've done time all over the country; from NY to CA. I've been in Attica with Mark Chapman and Corcoran with Charles Manson. After spending years in prison reading anything and everything I could get my hands on pertaining to finance and the economy, I decided that the real crooks did a lot less heavy lifting than I was used to, so I might as well give it a try - and now I trade stocks. I've had an inordinate amount of success in picking them, and I have an eerie ability to be able to call where a particular stock's price is going to by analyzing historical charts.
You can follow my trades throughout the day on Twitter under the pseudonym Lord Blankfiend.